Federal Register / Vol. 62, No. 167 / Thursday, August 28, 1997 / Notices 45669

CPG entitled ‘‘Distributor Medical

Device Reporting.’’ Two copies of any

comments are to be submitted, except

that individuals may submit one copy.

Comments are to be identified with the

docket number found in brackets in the

heading of this document. The agency

will review all comments, but in issuing

a final CPG, need not specifically

address every comment. The agency

will make changes to the CPG in

response to comments, as appropriate. A

copy of the draft CPG and received

comments may be seen in the office

above between 9 a.m. and 4 p.m.,

Monday through Friday.

III. Electronic Access

Copies of the draft CPG may also be

downloaded to a personal computer

with access to the World Wide Web

(www). The Office of Regulatory Affairs

(ORA) and CDRH Home Pages include

the draft CPG and may be accessed at

‘‘http://www.fda.gov/ora’’ or ‘‘http://

www.fda.gov/cdrh’’ respectively. The

draft CPG will be available on the

Compliance References or Compliance

Information pages for ORA and CDRH

respectively.

Dated: August 15, 1997.

Gary Dykstra,

Acting Associate Commissioner for

Regulatory Affairs.

[FR Doc. 97–22702 Filed 8–27–97; 8:45 am]

BILLING CODE 4160–01–F

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Food and Drug Administration

Advisory Committee; Notice of Meeting

AGENCY: Food and Drug Administration,

HHS.

ACTION: Notice.

This notice announces a forthcoming

meeting of a public advisory committee

of the Food and Drug Administration

(FDA). The meeting will be open to the

public.

Name of Committee: Food Advisory

Committee.

General Function of the Committee:

To provide advice and

recommendations to the agency on FDA

regulatory issues.

Date and Time: The meeting will be

held on September 25 and 26, 1997,

8:30 a.m. to 5 p.m.

Location: Holiday Inn—Eisenhower

Metro Center, Eisenhower Station

Ballroom, 2460 Eisenhower Ave.,

Alexandria, VA.

Contact Person: Lynn A. Larsen,

Center for Food Safety and Applied

Nutrition (HFS–5), Food and Drug

Administration, 200 C St. SW.,

Washington, DC 20204, 202–205–4727,

or Catherine M. DeRoever, Advisory

Committee Staff (HFS–22), 202–205–

4251, FAX 202–205–4970, or FDA

Advisory Committee Information Line,

1–800–741–8138 (301–443–0572 in the

Washington, DC area), code 10564.

Please call the Information Line for upto-date information on this meeting.

Agenda: The committee will be

conducting an informational meeting

during which it will be receiving

updates on past issues that were

referred to the committee and on other

activities related to food safety. There

will also be briefings by the current

working groups formed to discuss the

Final Report from the Keystone National

Policy Dialogue on Food, Nutrition, and

Health, as well as simultaneous working

group sessions. Two working groups are

expected to have work products for

committee discussion.

Procedure: Interested persons may

present data, information, or views,

orally or in writing, on issues pending

before the committee. Written

submissions may be made to the contact

person by September 17, 1997. Oral

presentations from the public will be

scheduled between approximately 4

p.m. and 5 p.m. on September 25, 1997.

Time allotted for each presentation may

be limited. Those desiring to make

formal oral presentations should notify

the contact person before September 17,

1997, and submit a brief statement of

the general nature of the evidence or

arguments they wish to present, the

names and addresses of proposed

participants, and an indication of the

approximate time requested to make

their presentation.

Notice of this meeting is given under

the Federal Advisory Committee Act (5

U.S.C. app. 2).

Dated: August 21, 1997.

Michael A. Friedman,

Deputy Commissioner for Operations.

[FR Doc. 97–22854 Filed 8–27–97; 8:45 am]

BILLING CODE 4160–01–F

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Food and Drug Administration

Mammography Workshop

AGENCY: Food and Drug Administration,

HHS.

ACTION: Notice.

The Food and Drug Administration

(FDA) is announcing the following

public workshop: Mammography

Workshop. The topics to be discussed

are: Update on the Mammography

Quality Standards Act (MQSA), State

regulations on mammography, the

medical physicist’s responsibilities,

FDA’s MQSA compliance, the

radiographic processor, and preparation

for the MQSA inspection.

Date and Time: The public workshop

will be held on Tuesday, September 23,

1997, 8:30 a.m. to 5 p.m.; registration, 8

a.m. to 8:30 a.m. Registration will close

on September 16, 1997.

Location: The public workshop will

be held at the Medical Forum Bldg., 950

22d St. North, Birmingham, AL 35203,

205–458–8800.

Contact: Ralph T. Trout, Food and

Drug Administration (HFR–SE19), 60

Eighth St. NE., Atlanta, GA 30309, 404–

347–4001, ext. 5248, FAX 404–347–

4349.

Registration: Send registration

information (including name, title, firm

name, address, telephone, and fax

number) to the contact person by

Tuesday, September 16, 1997. Space is

limited, therefore interested parties are

encouraged to register early.

If you need special accommodations

due to a disability, please contact Ralph

T. Trout at least 7 days in advance.

SUPPLEMENTARY INFORMATION: This

workshop is being sponsored by FDA’s

Southeast Region and the radiological

health programs of the States of the

Southeast Region. These States are

Alabama, Florida, Georgia, Louisiana,

Mississippi, North Carolina, South

Carolina, and Tennessee, and the

Commonwealth of Puerto Rico and the

Virgin Islands. The purpose of this

workshop is to provide mammography

facilities with an update on MQSA and

technical training in the area of

mammography.

Dated: August 22, 1997.

William B. Schultz,

Deputy Commissioner for Policy.

[FR Doc. 97–22980 Filed 8–25–97; 4:44 pm]

BILLING CODE 4160–01–F

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Food and Drug Administration

Medicated Feed Good Manufacturing

Practices (GMP’s) Training Workshop

AGENCY: Food and Drug Administration,

HHS.

ACTION: Notice.

SUMMARY: The Food and Drug

Administration (FDA), Office of

Regulatory Affairs (ORA), Pacific Region

is announcing a training workshop to